Department for Obstetrics and Fetal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Front Immunol. 2020 Jan 22;10:3017. doi: 10.3389/fimmu.2019.03017. eCollection 2019.
Maternal glucocorticoids critically rise during pregnancy reaching up to a 20-fold increase of mid-pregnancy concentrations. Concurrently, another steroid hormone, progesterone, increases. Progesterone, which shows structural similarities to glucocorticoids, can bind the intracellular glucocorticoid receptor, although with lower affinity. Progesterone is essential for the establishment and continuation of pregnancy and it is generally acknowledged to promote maternal immune tolerance to fetal alloantigens through a wealth of immunomodulatory mechanisms. Despite the potent immunomodulatory capacity of glucocorticoids, little is known about their role during pregnancy. Here we aim to compare general aspects of glucocorticoids and progesterone during pregnancy, including shared common steroidogenic pathways, plasma transporters, regulatory pathways, expression of receptors, and mechanisms of action in immune cells. It was recently acknowledged that progesterone receptors are not ubiquitously expressed on immune cells and that pivotal features of progesterone induced- maternal immune adaptations to pregnancy are mediated via the glucocorticoid receptor, including e.g., T regulatory cells expansion. We hypothesize that a tight equilibrium between progesterone and glucocorticoids is critically required and recapitulate evidence supporting that their disequilibrium underlie pregnancy complications. Such a disequilibrium can occur, e.g., after maternal stress perception, which triggers the release of glucocorticoids and impair progesterone secretion, resulting in intrauterine inflammation. These endocrine misbalance might be interconnected, as increase in glucocorticoid synthesis, e.g., upon stress, may occur in detriment of progesterone steroidogenesis, by depleting the common precursor pregnenolone. Abundant literature supports that progesterone deficiency underlies pregnancy complications in which immune tolerance is challenged. In these settings, it is largely yet undefined if and how glucocorticoids are affected. However, although progesterone immunomodulation during pregnancy appear to be chiefly mediated glucocorticoid receptors, excess glucocorticoids cannot compensate by progesterone deficiency, indicating that additional und still undercover mechanisms are at play.
孕期母体糖皮质激素水平会急剧上升,达到妊娠中期浓度的 20 倍。与此同时,另一种甾体激素——孕酮也在增加。孕酮与糖皮质激素结构相似,可以与细胞内糖皮质激素受体结合,尽管亲和力较低。孕酮对于妊娠的建立和维持是必不可少的,并且通过丰富的免疫调节机制被普遍认为可以促进母体对胎儿同种抗原的免疫耐受。尽管糖皮质激素具有强大的免疫调节能力,但人们对其在妊娠期间的作用知之甚少。在这里,我们旨在比较妊娠期间糖皮质激素和孕酮的一般方面,包括共享的常见甾体生成途径、血浆转运蛋白、调节途径、受体表达和在免疫细胞中的作用机制。最近人们认识到,孕酮受体并非在免疫细胞上普遍表达,孕酮诱导的母体对妊娠的免疫适应的关键特征是通过糖皮质激素受体介导的,例如 T 调节细胞的扩增。我们假设孕酮和糖皮质激素之间的紧密平衡是至关重要的,并回顾支持其失衡是妊娠并发症基础的证据。这种失衡可能会发生,例如在母体感知应激后,应激会触发糖皮质激素的释放并损害孕酮的分泌,导致宫内炎症。这种内分泌失衡可能是相互关联的,因为应激时糖皮质激素合成的增加,例如,可能会以消耗共同前体孕烯醇酮的方式损害孕酮的甾体生成。大量文献支持孕酮缺乏是免疫耐受受到挑战的妊娠并发症的基础。在这些情况下,尚不清楚糖皮质激素是否受到影响以及如何受到影响。然而,尽管孕酮在妊娠期间的免疫调节似乎主要是通过糖皮质激素受体介导的,但由于孕酮缺乏,过量的糖皮质激素无法代偿,这表明存在其他尚未发现的机制在起作用。